Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term efficacy and safety of CP-945,598 for prevention of weight regain in obese subjects
2007-000703-15Phase 3Completed
- Sponsor
- Pfizer
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obesity comparing CP-945,598 with Placebo (2 arms). Primary endpoint: Percent weight regained. Started May 2007; status: completed.
02
Drugs
otenabant
03
Conditions
obesity
Beyond the preview
Go deeper on 2007-000703-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000703-15.